No Data
No Data
CNS Pharmaceuticals to Participate in the Virtual Investor Closing Bell Series
CNS Pharmaceuticals Files Prospectus for Sale of Up to 2.4 Million Shares by Stockholders
CNS Pharmaceuticals CNSP Offering; ReShape RSLS Patent
Renalytix RNLX Steno Deal; CNS Pharmaceuticals CNSP NASDAQ Compliance
CNS Pharmaceutical Files for 2.36M Offering of Common Stock
Express News | CNS Pharmaceuticals - on July 5, Received Letter From Nasdaq Notifying Co That It Had Regained Compliance With Bid Price Rule
No Data